These requirements necessitate further research efforts, and we are in the process of establishing prospective multi-center clinical trials to acquire more accurate data. At last, the intrinsic relationship between Ki-67 expression and FDG-avidity in HCC tumor remains unclear, these may require more laboratory research work by more people. Here, MKI67 is linked to hepatocellular carcinoma.